A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2
Clinical trial NCT01480323 · COMPLETED
Trial details
- NCT number
- NCT01480323
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.